Literature DB >> 21791832

Difficulties in diagnosing slowly progressive mucopolysaccharidosis VI: A case series.

Maurizio Scarpa1, Ebba Buffone, Philipp La Marca, Mauro Campello, Angelica Rampazzo.   

Abstract

An Erratum for this article can be found here: http://iospress.metapress.com/content/e16437020701m0u5/?p=df8dd6709cf44367a0c0e5d917aaeddf&pi=11We describe the cases of two adult sisters recently diagnosed with the attenuated form of mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy syndrome). MPS VI is a rare, clinically heterogeneous lysosomal storage disorder that is characterized by a deficiency in the glycosaminoglycan-degrading enzyme arylsulfatase B. Both cases had been misdiagnosed for over 30 years despite the presence of several characteristics of the disease, including short stature (mild), coarse facial features, skeletal dysmorphisms, carpal tunnel syndrome, heart valve disease, and spinal cord compression, which together are suggestive of a lysosomal storage disease. Awareness about the clinical features of MPS VI should be communicated amongst treating neurologists, rheumatologists and other specialists who are involved in the healthcare decisions of these patients with presenting symptoms, so they can refer them to specialized centers for proper diagnosis and treatment.

Entities:  

Year:  2010        PMID: 21791832     DOI: 10.3233/PRM-2010-0104

Source DB:  PubMed          Journal:  J Pediatr Rehabil Med        ISSN: 1874-5393


  9 in total

1.  Clinical characteristics of adults with slowly progressing mucopolysaccharidosis VI: a case series.

Authors:  Anke Thümler; Elke Miebach; Christina Lampe; Susanne Pitz; Wolfgang Kamin; Christoph Kampmann; Bianca Link; Eugen Mengel
Journal:  J Inherit Metab Dis       Date:  2012-03-23       Impact factor: 4.982

2.  Mucopolysaccharidoses diagnosis in the era of enzyme replacement therapy in Egypt.

Authors:  Ekram Fateen; Zeinab Y Abdallah; Walaa S Nazim; Mona Ibrahim; Amira Radwan
Journal:  Heliyon       Date:  2021-08-19

3.  ARSB gene variants causing Mucopolysaccharidosis VI in Miniature Pinscher and Miniature Schnauzer dogs.

Authors:  K Raj; L Berman-Booty; P Foureman; U Giger
Journal:  Anim Genet       Date:  2020-09-28       Impact factor: 3.169

4.  Craniocervical decompression in patients with mucopolysaccharidosis VI: development of a scoring system to determine indication and outcome of surgery.

Authors:  Christina Lampe; Christian Lampe; Manfred Schwarz; Wibke Müller-Forell; Paul Harmatz; Eugen Mengel
Journal:  J Inherit Metab Dis       Date:  2013-02-14       Impact factor: 4.982

5.  Mucopolysaccharidosis VI: cardiac involvement and the impact of enzyme replacement therapy.

Authors:  Christoph Kampmann; Christina Lampe; Catharina Whybra-Trümpler; Christiane M Wiethoff; Eugen Mengel; Laila Arash; Michael Beck; Elke Miebach
Journal:  J Inherit Metab Dis       Date:  2013-09-24       Impact factor: 4.982

6.  Mucopolysaccharidosis IVA (Morquio A syndrome) and VI (Maroteaux-Lamy syndrome): under-recognized and challenging to diagnose.

Authors:  Ralph S Lachman; Barbara K Burton; Lorne A Clarke; Scott Hoffinger; Shiro Ikegawa; Dong-Kyu Jin; Hiroki Kano; Ok-Hwa Kim; Christina Lampe; Nancy J Mendelsohn; Renée Shediac; Pranoot Tanpaiboon; Klane K White
Journal:  Skeletal Radiol       Date:  2014-01-04       Impact factor: 2.199

7.  Non-clinical Safety and Efficacy of an AAV2/8 Vector Administered Intravenously for Treatment of Mucopolysaccharidosis Type VI.

Authors:  Rita Ferla; Marialuisa Alliegro; Jean-Brice Marteau; Margherita Dell'Anno; Edoardo Nusco; Severine Pouillot; Stefania Galimberti; Maria Grazia Valsecchi; Vincent Zuliani; Alberto Auricchio
Journal:  Mol Ther Methods Clin Dev       Date:  2017-07-24       Impact factor: 6.698

Review 8.  Attenuated osteoarticular phenotype of type VI mucopolysaccharidosis: a report of four patients and a review of the literature.

Authors:  Agnieszka Jurecka; Ekaterina Zakharova; Vera Malinova; Elena Voskoboeva; Anna Tylki-Szymańska
Journal:  Clin Rheumatol       Date:  2013-11-13       Impact factor: 2.980

Review 9.  Mucopolysaccharidosis Type VI, an Updated Overview of the Disease.

Authors:  Francesca D'Avanzo; Alessandra Zanetti; Concetta De Filippis; Rosella Tomanin
Journal:  Int J Mol Sci       Date:  2021-12-15       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.